In common with B-ALL, the incidence of acute megakaryoblastic leukaemia (AMKL) is highly elevated in individuals with DS and Dyrk1A dosage increase was shown to co-operate with Gata1 and Mpl mutations to promote AMKL [51]. The gene discussed is MPL; the disease is Dravet syndrome.